3-Bromo-1-(3-chloropyridin-2-yl)-1H-pyrazole-5-carbonyl chloride, 95.0%, 1g

(S)-5-Bromo-1,2,3,4-tetrahydronaphthalen-1-amine hydrochloride, 95.0%, 250mg

1-(4-Benzyl-piperazin-1-yl)-2-chloro-ethanone; hydrochloride, 250mg

(S)-4-Benzyl 1-tert-butyl 2-aminosuccinate hydrochloride, 95.0%, 5g

Methyl 5,5-dimethyl-2-oxocyclohexane-1-carboxylate, 95%, 1g

2-{[5-(4-chlorophenyl)-4-(furan-2-ylmethyl)-4h-1,2,4-triazol-3-yl]sulfanyl}acetic acid, 97%, 100mg

(S)-2,2,2-Trifluoro-1-(3-(trifluoromethyl)phenyl)ethanamine, 95.0%, 250mg

tert-Butyl 3-allyl-3-hydroxyazetidine-1-carboxylate, 95+%, 1g

4-ethyl-5-hydroxy-7-methyl-2H-chromen-2-one, 95.0%, 5g

Microliter syringe MICROLITER® series 7000 Point type 2, 5.0 µl, 7105 KH, 1 piece

2-Fluoro-5-iodopyridin-4-amine, 98%, 100mg

4-PYRROLIDINOPIPERIDINE 2HCL, 97.0%, 250mg

(R)-1-Boc-2-Piperidineacetic acid, 95.0%, 250mg